Meet the Investigators
Transforming Research Into Better Lives for WM Patients
Leaders in Innovation.
Partners in Care.
The nation’s foremost WM clinicians and scientists united to accelerate progress.
Behind every WM-Net study is a community of dedicated clinician-scientists driven by a shared vision: improving outcomes for individuals with Waldenström’s macroglobulinemia.
WM-Net’s leadership includes its founding director, Dr. Jorge Castillo (Dana-Farber Cancer Institute), and a national team of investigators representing 24 leading academic medical centers.
Clinical Director, Bing Center for Waldenström Macroglobulinemia
Associate Professor of Medicine, Harvard Medical School
Dana-Farber Cancer Institute, Boston, MA
Chair of the Mayo Clinic Waldenström Macroglobulinemia Working Group
Associate Professor of Medicine, Mayo Clinic
Division of Hematology, Mayo Clinic, Rochester, MN
Member, Lymphoma Service
MSK Lymphoma Specialist and Cellular Therapist
Memorial Sloan-Kettering Cancer Center, New York, NY
Professor, Department of Lymphoma/Myeloma, Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center, Houston, TX
Our 24 Academic Centers
